Prevalence and Factors Associated with Tuberculosis Treatment Success among TB/HIV Co-Infection in North-East Malaysia

Tengku Mardhiah Tengku Jalal, Sarimah Abdullah, Farhanah Abd Wahab, Sharina Dir, Nyi Nyi Naing, Tengku Mardhiah Tengku Jalal, Sarimah Abdullah, Farhanah Abd Wahab, Sharina Dir, Nyi Nyi Naing

Abstract

Background: One of the six strategies developed by WHO, in order to stop Tuberculosis (TB) is addressing TB/HIV high-risk groups. This study aimed to determine the prevalence of successful TB treatment and factors associated with TB treatment success among TB/HIV co-infection patients in North-East Malaysia.

Methods: A cross-sectional study was carried out in the a-year period from 2003 to 2012 by reviewing TB/HIV records in all hospitals and health clinics. The outcome of interest was treatment success as defined by Ministry of Health (MOH) when the patients was cured or completed TB treatment.

Results: Out of 1510 total TB/HIV co-infection cases, 27.9% (95% CI: 25.2, 30.6) of the patients were having treatment success. A majority of TB/HIV co-infection cases were male (91.1%). Fifty-eight percent the patients were drug addicts and 6% were having positive tuberculin tests. The multiple logistic regression revealed that male (OR: 0.39, 95% CI: 0.22, 0.71) and positive tuberculin test result (OR: 2.61, 95% CI: 1.63, 4.19) were significantly associated with the treatment success of TB/HIV co-infection patients. Other factors such as age, comorbid, sputum smear and x-ray findings were not significantly factors in this study.

Conclusion: Female patients and those with negative tuberculin test should be emphasised for successful tuberculosis treatment.

Keywords: BCG; TB/HIV co-infection; successful tuberculosis treatment; tuberculin test; tuberculosis.

References

    1. Yoon CM. TB, the diehard disease. The Star; Jul 29, 2010. Retrieved January 2, 2014, from .
    1. Lazarus JV, Olsen M, Ditiu L, Matic S. Tuberculosis-HIV co-infection: policy and epidemiology in 25 countries in the WHO European region. HIV Med. 2008;9(6):406–414. .
    1. HIV Coinfections. AIDSinfo; 2012. Retrieved April 13, 2014, from .
    1. Ministry of Health Malaysia. Clinical Practice Guidelines - Management of Tuberculosis (Third Edition) Malaysia: Malaysia Health Technology Assessment Section (MaHTAS); 2012. .
    1. World Health Organization. The Stop TB Strategy-Building on and enhancing DOTS to meet the TB-related Millennium Development Goals. World Health Organization; 2006. .
    1. Nissapatorn V, Kuppusamy I, Sim BL, Quek KF, Khairul Anuar A. Tuberculosis in HIV/AIDS patients: a Malaysian experience. Southeast Asian J Trop Med Public Health. 2005;36(4):946–953.
    1. Mohammad Z, Naing NN. Characteristics of HIV-infected tuberculosis patients in Kota Bharu Hospital, Kelantan from 1998 to 2001. Southeast Asian J Trop Med Public Health. 2004;35(1):140–143.
    1. Kapata N, Chanda-Kapata P, O’Grady J, Schwank S, Bates M, Mukonka, et al. Trends of Zambia’s tuberculosis burden over the past two decades. Trop Med Int Health. 2011;16(11):1404–1409. .
    1. Mishra P, Hansen EH, Sabroe S, Kafle KK. Socio-economic status and adherence to tuberculosis treatment: a case-control study in a district of Nepal. Int J Tuberc Lung Dis. 2005;9(10):1134–1139.
    1. Maher D. Health care in-depth. Tuberculosis and HIV. Afr Health. 1996;19(1):17–18.
    1. Nik Nor Ronaidi NM, Mohd NS, Wan Mohammad Z, Sharina D, Nik Rosmawati NH. Factors associated with unsuccessful treatment outcome of pulmonary tuberculosis in Kota Bharu, Kelantan. Malays J of Public Health Medic. 2011;11(1):6–15.
    1. Alisjahbana B, Sahiratmadja E, Nelwan EJ, Purwa AM, Ahmad Y, Ottenhoff TH, van Crevel R. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clin Infect Dis. 2007;45(4):428–435. .
    1. Naing NN, D’Este C, Isa AR, Salleh R, Bakar N, Mahmod MR. Factors contributing to poor compliance with anti-TB treatment among tuberculosis patients. Southeast Asian J Trop Med Public Health. 2001;32(2):369–382.
    1. Balbay O, Annakkaya AN, Arbak P, Bilgin C, Erbas M. Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. J Infect Dis. 2005;58:152–158.
    1. Dupont WD, Plummer WD. PS power and sample size program available for free on the Internet. Controlled Clin Trials. 1997;18:274. .
    1. Berhe G, Enquselassie F, Aseffa A. BMC Public Health. 2012;23(12):537. .
    1. Ismail I, Bulgiba A. Determinants of unscuccessful tuberculosis treatment outcomes in Malaysian HIV-infected patients. Preventive Medicine. 2013;57:S27–S30. .
    1. Tweya H, Feldacker C, Phiri S, Ben-Smith A, Fenner L, Jahn A, et al. Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi. PLoS ONE. 2013;8(2):e56248. .
    1. Oshi DC, Oshi SN, Alobu I, Ukwaja KN. Profile, outcomes, and determinants of unsuccessful tuberculosis treatment outcomes among HIV-infected tuberculosis patients in a Nigerian State. Tuberculosis Research and Treatment. 2014;2014:8 p. .
    1. NHS. Who should have the BCG (TB) vaccine? NHS; Retrieved April 29, 2014, from .
    1. World Health Organization European Region. Chapter 4 management of tuberculosis and HIV coinfection: clinical protocol for the WHO European region. Retrieved September 5, 2016, from .
    1. Dye C, Floyd K. Disease control priorities in developing countries. In: Jamison DT, Breman JG, Measham AR, et al., editors. Chapter 16 Tuberculosis. 2nd edition. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2006. Retrieved September 5, 2016, from .

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe